Diaphorina citri psyllid: psy14674

Local Sequence Feature Prediction

Prediction and Method	Result

Residue Number Marker

Protein Sequence

Secondary Structure (Consensus)

Disordered Region (Consensus)

Transmembrane Helix (Consensus)

Signal Peptide (Consensus)

Coiled Coil (COILS)

--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------52

MSSRIISRSGYDAKSSNSKPSQQNGDSKDENVQCEDMTSRDYYFDSYAHFGIHEEMLKDEVRTMTYRNSMYHNKHLFKGKIVLDIGCGTGILSMFAAKSGAARVIGIECSNIVEYAKEIVDKNNLSDVVTILKGKVEEVELPFGIQKVDIIISEWMGYCLFYESMLDTVLYARDKWLATNGLLFPDKASLFICGIEDLQGGQDHVVGQCVRVLFPDKASLFICGIEDRQYKEDKITWWDNVYGFDMSCIKKIAIKEPLVDVVDPKQVVTSSCLLKEIDLYTITKADLSFTSPFTLQVRRNDYVQALVTFFSVEFSKCHKRIGFSTAPEAHYTHWKQTVFYLNEHLTVKKGEEVVGSFGMQPNPRNNRDLDFTVEVNFKGELCEMSESNDYQVDDRLAALGLRDRDCMYTKLYTIVHAPFTLQVRRNDYVQALVTFFSVEFSKCHKRIGFSTAPEAHYTHWKQTVFYLNEHLTVKKGEEVVGSFGMQPNPRNNRDLDFTVEVNFKGELCEMSESNDYRMR

ccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHcccHHHHHHHHHHHcccccccccEEEEEcccccHHHHHHHHHcccEEEEEcccHHHHHHHHHHHHccccccEEEEEcEEEEECccccccccEEEEEccccccccccHHHHHHHHHHHHccccccEEcccccEEEEEEECcccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccEEECcccccEEccccEEEEEEccccccccccEEEcEEEEEEEccEEEEEEEEEEEEEccccccCEEEccccccccccEEEEEEcccEEEEccccEEEEEEEEEEcccccCEEEEEEEEEEcccCCccccccccccccHHHHcccccccccEEEEEEEECccEEEEEEEccEEEEEEEEEEEEEcccccCEEEEccccccccccEEEEEEcccEEEEccccEEEEEEEEEEcccccccEEEEEEEEEcccCEEEEEEEEEEcc

**************************************SRDYYFDSYAHFGIHEEMLKDEVRTMTYRNSMYHNKHLFKGKIVLDIGCGTGILSMFAAKSGAARVIGIECSNIVEYAKEIVDKNNLSDVVTILKGKVEEVELPFGIQKVDIIISEWMGYCLFYESMLDTVLYARDKWLATNGLLFPDKASLFICGIEDLQGGQDHVVGQCVRVLFPDKASLFICGIEDRQYKEDKITWWDNVYGFDMSCIKKIAIKEPLVDVVDPKQVVTSSCLLKEIDLYTITKADLSFTSPFTLQVRRNDYVQALVTFFSVEFSKCHKRIGFSTAPEAHYTHWKQTVFYLNEHLTVKKGEEVVGSFGMQPNPRNNRDLDFTVEVNFKGELCEMSESNDYQVDDRLAALGLRDRDCMYTKLYTIVHAPFTLQVRRNDYVQALVTFFSVEFSKCHKRIGFSTAPEAHYTHWKQTVFYLNEHLTVKKGEEVVGSFGMQPNPRNNRDLDFTVEVNFKGELCEMSESNDYRMR

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
Protein arginine N-methyltransferase 1	Arginine methyltransferase that methylates (mono and asymmetric dimethylation) the guanidino nitrogens of arginyl residues present in proteins such as ESR1, histone H2, H3 and H4, PIAS1, HNRNPA1, HNRNPD, NFATC2IP, SUPT5H, TAF15 and EWS. Constitutes the main enzyme that mediates monomethylation and asymmetric dimethylation of histone H4 'Arg-4' (H4R3me1 and H4R3me2a, respectively), a specific tag for epigenetic transcriptional activation. Together with dimethylated PIAS1, represses STAT1 transcriptional activity, in the late phase of interferon gamma (IFN-gamma) signaling. May be involved in the regulation of TAF15 transcriptional activity, act as an activator of estrogen receptor (ER)-mediated transactivation, play a key role in neurite outgrowth and act as a negative regulator of megakaryocytic differentiation, by modulating p38 MAPK pathway.	confident	Q99873
Probable protein arginine N-methyltransferase 1	Methylates (mono and asymmetric dimethylation) the guanidino nitrogens of arginyl residues present in a glycine and arginine-rich domain (can methylate histones).	confident	Q0J2C6
Protein arginine N-methyltransferase 1	Arginine methyltransferase that methylates (mono and asymmetric dimethylation) the guanidino nitrogens of arginyl residues present in proteins such as ESR1, histone H2, H3 and H4, PIAS1, HNRNPA1, HNRNPD, NFATC2IP, SUPT5H, TAF15 and EWS. Constitutes the main enzyme that mediates monomethylation and asymmetric dimethylation of histone H4 'Arg-4' (H4R3me1 and H4R3me2a, respectively), a specific tag for epigenetic transcriptional activation. Together with dimethylated PIAS1, represses STAT1 transcriptional activity, in the late phase of interferon gamma (IFN-gamma) signaling. May be involved in the regulation of TAF15 transcriptional activity, act as an activator of estrogen receptor (ER)-mediated transactivation, play a key role in neurite outgrowth and act as a negative regulator of megakaryocytic differentiation, by modulating p38 MAPK pathway.	confident	Q63009

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0019919 [BP]	peptidyl-arginine methylation, to asymmetrical-dimethyl arginine	probable	GO:0006479, GO:0008213, GO:0035246, GO:0035247, GO:0044267, GO:0044260, GO:0018216, GO:0018193, GO:0071704, GO:0032259, GO:0009987, GO:0006464, GO:0043412, GO:0036211, GO:0008150, GO:0008152, GO:0044238, GO:0019538, GO:0044237, GO:0043170, GO:0018195, GO:0043414
GO:0005829 [CC]	cytosol	probable	GO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0035241 [MF]	protein-arginine omega-N monomethyltransferase activity	probable	GO:0016274, GO:0016273, GO:0003824, GO:0008757, GO:0016740, GO:0016741, GO:0008170, GO:0008276, GO:0003674, GO:0008168
GO:0035242 [MF]	protein-arginine omega-N asymmetric methyltransferase activity	probable	GO:0016274, GO:0016273, GO:0003824, GO:0008757, GO:0016740, GO:0016741, GO:0008170, GO:0008276, GO:0003674, GO:0008168
GO:0044020 [MF]	histone methyltransferase activity (H4-R3 specific)	probable	GO:0016274, GO:0042054, GO:0016273, GO:0003824, GO:0008757, GO:0016740, GO:0016741, GO:0008469, GO:0008170, GO:0008276, GO:0003674, GO:0008168
GO:0048468 [BP]	cell development	probable	GO:0032502, GO:0048856, GO:0048869, GO:0030154, GO:0044767, GO:0044763, GO:0008150, GO:0009987, GO:0044699
GO:0043985 [BP]	histone H4-R3 methylation	probable	GO:0006479, GO:0008213, GO:0044699, GO:0044267, GO:0044260, GO:0006325, GO:0071840, GO:0016043, GO:0071704, GO:0034969, GO:0016571, GO:0016570, GO:0032259, GO:0009987, GO:0006464, GO:0043412, GO:0036211, GO:0043414, GO:0008152, GO:0006996, GO:0044238, GO:0051276, GO:0019538, GO:0044763, GO:0044237, GO:0043170, GO:0008150, GO:0016568, GO:0016569
GO:0005783 [CC]	endoplasmic reticulum	probable	GO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0043234 [CC]	protein complex	probable	GO:0005575, GO:0032991
GO:0009653 [BP]	anatomical structure morphogenesis	probable	GO:0032502, GO:0048856, GO:0008150
GO:0046982 [MF]	protein heterodimerization activity	probable	GO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0022008 [BP]	neurogenesis	probable	GO:0032502, GO:0048856, GO:0044707, GO:0007399, GO:0048869, GO:0030154, GO:0008150, GO:0032501, GO:0044763, GO:0048731, GO:0009987, GO:0007275, GO:0044699
GO:0048518 [BP]	positive regulation of biological process	probable	GO:0008150, GO:0065007, GO:0050789
GO:0045653 [BP]	negative regulation of megakaryocyte differentiation	probable	GO:0051093, GO:0050793, GO:0045652, GO:0045595, GO:0050794, GO:0050789, GO:0045596, GO:0045638, GO:0065007, GO:0002682, GO:0008150, GO:0051239, GO:0048519, GO:2000026, GO:0045637, GO:0048523
GO:0070611 [MF]	histone methyltransferase activity (H3-R2 specific)	probable	GO:0016274, GO:0042054, GO:0016273, GO:0003824, GO:0008757, GO:0016740, GO:0016741, GO:0008469, GO:0008170, GO:0008276, GO:0003674, GO:0008168
GO:0001701 [BP]	in utero embryonic development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0005730 [CC]	nucleolus	probable	GO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0042803 [MF]	protein homodimerization activity	probable	GO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0030519 [MF]	snoRNP binding	probable	GO:0043021, GO:0003674, GO:0005488
GO:0005886 [CC]	plasma membrane	probable	GO:0005575, GO:0044464, GO:0016020, GO:0071944, GO:0005623
GO:0045892 [BP]	negative regulation of transcription, DNA-dependent	probable	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0010558, GO:0048523
GO:0034970 [BP]	histone H3-R2 methylation	probable	GO:0006479, GO:0008213, GO:0044699, GO:0044267, GO:0044260, GO:0006325, GO:0071840, GO:0016043, GO:0071704, GO:0034969, GO:0016571, GO:0016570, GO:0032259, GO:0009987, GO:0006464, GO:0043412, GO:0036211, GO:0043414, GO:0008152, GO:0006996, GO:0044238, GO:0051276, GO:0019538, GO:0044763, GO:0044237, GO:0043170, GO:0008150, GO:0016568, GO:0016569

Prediction of Enzyme Commission Number

No confident prediction of EC number!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3Q7E, chain A
Confidence level:very confident
Coverage over the Query: 49-189,220-393
View the alignment between query and template
View the model in PyMOL

Template: 3Q7E, chain A
Confidence level:very confident
Coverage over the Query: 399-519
View the alignment between query and template
View the model in PyMOL